This title appears in the Scientific Report :
2008
Please use the identifier:
http://dx.doi.org/10.1007/s00259-008-0853-7 in citations.
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
Saved in:
Personal Name(s): | Verbruggen, A. |
---|---|
Coenen, H. H. / Deverre, J.R. / Guilloteau, D. / Langstrom, B. / Salvadori, P.A. / Halldin, C. | |
Contributing Institute: |
Nuklearchemie; INM-5 |
Published in: | European journal of nuclear medicine and molecular imaging, 35 (2008) S. 2144 - 2151 |
Imprint: |
Heidelberg [u.a.]
Springer-Verl.
2008
|
Physical Description: |
2144 - 2151 |
DOI: |
10.1007/s00259-008-0853-7 |
Document Type: |
Journal Article |
Research Program: |
Funktion und Dysfunktion des Nervensystems |
Series Title: |
European Journal of Nuclear Medicine and Molecular Imaging
35 |
Publikationsportal JuSER |
LEADER | 02659nam a2200613 a 4500 | ||
---|---|---|---|
001 | 7916 | ||
005 | 20180208231536.0 | ||
024 | 7 | |a 1619-7070 |2 ISSN | |
024 | 7 | |2 ISSN |a 1432-105X | |
024 | 7 | |a 10.1007/s00259-008-0853-7 |2 DOI | |
024 | 7 | |a WOS:000259909600026 |2 WOS | |
037 | |a PreJuSER-7916 | ||
082 | |a 610 | ||
100 | 1 | |a Verbruggen, A. |b 0 |0 P:(DE-HGF)0 | |
245 | |a Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU | ||
260 | |c 2008 |a Heidelberg [u.a.] |b Springer-Verl. | ||
300 | |a 2144 - 2151 | ||
440 | 0 | |a European Journal of Nuclear Medicine and Molecular Imaging |x 1619-7070 |0 9906 |v 35 | |
500 | |a Record converted from VDB: 12.11.2012 | ||
700 | 1 | |a Coenen, H. H. |b 1 |u FZJ |0 P:(DE-Juel1)131816 | |
700 | 1 | |a Deverre, J.R. |b 2 |0 P:(DE-HGF)0 | |
700 | 1 | |a Guilloteau, D. |b 3 |0 P:(DE-HGF)0 | |
700 | 1 | |a Langstrom, B. |b 4 |0 P:(DE-HGF)0 | |
700 | 1 | |a Salvadori, P.A. |b 5 |0 P:(DE-HGF)0 | |
700 | 1 | |a Halldin, C. |b 6 |0 P:(DE-HGF)0 | |
773 | |g Vol. 35, p. 2144 - 2151 |p 2144 - 2151 |q 35<2144 - 2151 |0 PERI:(DE-600)2098375-X |v 35 |y 2008 |x 1619-7070 |t European journal of nuclear medicine and molecular imaging | ||
909 | C | O | |o oai:juser.fz-juelich.de:7916 |p VDB |
913 | 1 | |k P33 |v Funktion und Dysfunktion des Nervensystems |l Funktion und Dysfunktion des Nervensystems |b Gesundheit |0 G:(DE-Juel1)FUEK409 |x 0 | |
914 | 1 | |a Nachtrag |y 2008 | |
915 | |a JCR/ISI refereed |0 StatID:(DE-HGF)0010 |2 StatID | ||
915 | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List | ||
970 | |a VDB:(DE-Juel1)116698 | ||
980 | |a VDB | ||
980 | |a ConvertedRecord | ||
980 | |a journal | ||
980 | |a I:(DE-Juel1)INM-5-20090406 | ||
980 | |a UNRESTRICTED | ||
536 | |a Funktion und Dysfunktion des Nervensystems |c P33 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK409 |x 0 | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) | ||
336 | |a article |2 DRIVER | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
920 | |k Nuklearchemie; INM-5 |l Nuklearchemie |g INM |0 I:(DE-Juel1)INM-5-20090406 |x 0 | ||
990 | |a Verbruggen, A. |b 0 |0 P:(DE-HGF)0 | ||
991 | |a Halldin, C. |b 6 |0 P:(DE-HGF)0 | ||
991 | |a Salvadori, P.A. |b 5 |0 P:(DE-HGF)0 | ||
991 | |a Langstrom, B. |b 4 |0 P:(DE-HGF)0 | ||
991 | |a Guilloteau, D. |b 3 |0 P:(DE-HGF)0 | ||
991 | |a Deverre, J.R. |b 2 |0 P:(DE-HGF)0 | ||
991 | |a Coenen, Heinrich Hubert |b 1 |u FZJ |0 P:(DE-Juel1)131816 |